Kimberly L. Rockley
AstraZeneca (United Kingdom)(GB)Redx Pharma (United Kingdom)(GB)Bodycote (United Kingdom)(GB)
Publications by Year
Research Areas
Chemotherapy-induced cardiotoxicity and mitigation, Neuroscience and Neural Engineering, Metal complexes synthesis and properties, Electrochemical sensors and biosensors, Cardiac electrophysiology and arrhythmias
Most-Cited Works
- → Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics(2019)57 cited
- → Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors(2013)33 cited
- → Anticancer RuII and RhIII Piano‐Stool Complexes that are Histone Deacetylase Inhibitors(2016)20 cited
- → Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activity(2016)19 cited
- → An integrated approach for early in vitro seizure prediction utilizing hiPSC neurons and human ion channel assays(2023)16 cited
- → Innovative models for in vitro detection of seizure(2019)6 cited
- In Vitro Evaluation of Anthracycline-induced Cardiotoxicity and Mitigation by Perturbation of Angiotensin Signalling